Post-operative hypofractionated radiotherapy for prostate cancer: a mono-institutional analysis of toxicity and clinical outcomes-Reference-Cited by-同舟云学术

Post-operative hypofractionated radiotherapy for prostate cancer: a mono-institutional analysis of toxicity and clinical outcomes

Published:2021-09-30 Issue:1 Volume:148 Page:89-95
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Ferrera Giuseppe,D’Alessandro Salvatore,Cuccia Francesco^ORCID,Serretta Vincenzo,Trapani Giovanna,Savoca Gianfranco,Mortellaro Gianluca,Lo Casto Antonio

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00432-021-03816-y.pdf

Reference23 articles.

1. Alongi F, De Bari B, Franco P, Ciammella P, Chekrine T, Livi L, Jereczek-Fossa BA, Filippi AR, AIRO Young and AIRO Prostate cancer Working Group (2013) The PROCAINA (PROstate CAncer INdication Attitudes) Project (Part I): a survey among Italian radiation oncologists on postoperative radiotherapy in prostate cancer. Radiol Med 118(4):660–678. https://doi.org/10.1007/s11547-012-0913-8

2. Barra S, Belgioia L, Marcenaro M, Callegari S, Pastorino A, Trapani L, Cavagnetto F, Garelli S, Corvò R (2018) Moderate hypofractionated radiotherapy after prostatectomy for cancer patients: toxicity and clinical outcome. Cancer Manag Res 12(10):473–480. https://doi.org/10.2147/CMAR.S146131

3. Cozzarini C, Fiorino C, Deantoni C, Briganti A, Fodor A, La Macchia M, Noris Chiorda B, Rancoita PM, Suardi N, Zerbetto F, Calandrino R, Montorsi F, Di Muzio N (2014) Higher-than-expected severe (Grade 3–4) late urinary toxicity after postprostatectomy hypofractionated radiotherapy: a single-institution analysis of 1176 patients. Eur Urol 66(6):1024–1030. https://doi.org/10.1016/j.eururo.2014.06.012

4. Cuccia F, Mortellaro G, Serretta V, Valenti V, Tripoli A, Gueci M, Luca N, Lo Casto A, Ferrera G (2018) Hypofractionated postoperative helical tomotherapy in prostate cancer: a mono-institutional report of toxicity and clinical outcomes. Cancer Manag Res 29(10):5053–5060. https://doi.org/10.2147/CMAR.S182016

5. Dal Pra A, Abramowitz MC, Stoyanova R, Pollack A (2018) Contemporary role of postoperative radiotherapy for prostate cancer. Transl Androl Urol 7(3):399–413. https://doi.org/10.21037/tau.2018.06.01

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypofractionated Post-Prostatectomy Radiotherapy in 16 Fractions: A Single-Institution Outcome;Life;2023-07-23

2. Acute Toxicity and Quality of Life in a Post-Prostatectomy Ablative Radiation Therapy (POPART) Multicentric Trial;Current Oncology;2022-11-30

3. Moderately hypofractionated salvage radiotherapy in patients with biochemical recurrence of prostate cancer after prostatectomy: long-term results and comparative analysis of two schedules;Neoplasma;2022